Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 7 , ISSUE 1 ( January-June, 2017 ) > List of Articles

CASE REPORT

Persistent Elevation of CA 19-9 Levels in the Long-term Follow-up before Laryngeal Cancer

Fatih Karakaya, Zihni Karaeren, Sibel Perçinel

Citation Information : Karakaya F, Karaeren Z, Perçinel S. Persistent Elevation of CA 19-9 Levels in the Long-term Follow-up before Laryngeal Cancer. Euroasian J Hepatogastroenterol 2017; 7 (1):92-94.

DOI: 10.5005/jp-journals-10018-1222

License: CC BY 3.0

Published Online: 00-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction

CA 19-9 is used as a tumor marker in colon, pancreas, biliary, and gastric cancers. Laryngeal cancer is the most common malignant epithelial tumor among head and neck cancers and has no specific tumor marker.

Case report

A 66-year-old male patient had severe reflux symptoms during 5 years and had an isolated CA 19-9 elevation. Follow-up analysis revealed that he had larynx cancer and after laryngectomy, CA 19-9 levels decreased to normal range.

Discussion

Currently, CA 19-9 is not a marker for malignancy. Laryngeal carcinoma has no specific tumor marker, but laryngeal squamous cell carcinoma may be manifested by elevated CA 19-9 levels.

How to cite this article

Özkan H, Karakaya F, Karaeren Z, Perçinel S. Persistent Elevation of CA 19-9 Levels in the Long-term Follow-up before Laryngeal Cancer. Euroasian J Hepato-Gastroenterol 2017;7(1):92-94.


  1. CA 19-9: handle with care. Clin Chem Lab Med 2013 Jul;51(7):1369-1383.
  2. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014 Sep;19(6):437-443.
  3. The role of tumor markers and biomarkers in colorectal cancer. Neoplasma 2014;61(1):1-8.
  4. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology 2015;89(3):125-136.
  5. Expression of the carbohydrate tumor marker Sialyl-Lewis A (CA19-9) in squamous cell carcinoma of the larynx. Anticancer Res 2010 May;30(5):1849-1853.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.